Drug Shortage Report for SANDOZ POSACONAZOLE

Last updated on 2021-09-02 History
Report ID 140854
Drug Identification Number 02496259
Brand name SANDOZ POSACONAZOLE
Common or Proper name SANDOZ POSACONAZOLE
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) POSACONAZOLE
Strength(s) 100MG
Dosage form(s) TABLET (DELAYED-RELEASE)
Route of administration ORAL
Packaging size 60GRT BO CA
ATC code J02AC
ATC description ANTIMYCOTICS FOR SYSTEMIC USE
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2021-06-11
Estimated end date 2021-08-27
Actual end date 2021-08-30
Shortage status Resolved
Updated date 2021-09-02
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2021-09-02 French Compare
v11 2021-09-02 English Compare
v10 2021-08-16 French Compare
v9 2021-08-16 English Compare
v8 2021-08-09 French Compare
v7 2021-08-09 English Compare
v6 2021-06-28 French Compare
v5 2021-06-28 English Compare
v4 2021-06-21 French Compare
v3 2021-06-21 English Compare
v2 2021-06-14 French Compare
v1 2021-06-14 English Compare

Showing 1 to 12 of 12